Free Trial

Karyopharm Therapeutics (KPTI) News Today

Karyopharm Therapeutics logo
$4.48 -0.29 (-6.08%)
As of 10:54 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

KPTI Latest News

HC Wainwright Begins Coverage on Karyopharm Therapeutics (NASDAQ:KPTI)
Karyopharm Therapeutics Inc.DL-Exch. Notes 2018(25) Bond
Karyopharm Therapeutics (KPTI) Receives a Buy from Piper Sandler
Karyopharm price target lowered to $54 from $75 at Baird
Karyopharm trading halted, news pending
Karyopharm target adjusted to $7 from $56 at H.C. Wainwright
Karyopharm implementing 1-for-15 reverse stock split
Karyopharm Announces 1-for-15 Reverse Stock Split
Research Analysts Offer Predictions for KPTI Q1 Earnings
Analysts Set Expectations for KPTI Q1 Earnings
Barclays Sticks to Its Buy Rating for Karyopharm Therapeutics (KPTI)
Get Karyopharm Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KPTI and its competitors with MarketBeat's FREE daily newsletter.

KPTI Media Mentions By Week

KPTI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KPTI
News Sentiment

0.22

0.99

Average
Medical
News Sentiment

KPTI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KPTI Articles
This Week

6

2

KPTI Articles
Average Week

Get Karyopharm Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KPTI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:KPTI) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners